impact factor
logo
 

Letter

 

Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept


1, 2, 3, 4, 5, 6

 

  1. Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain.
  2. Rheumatology Research Group, Vall d’Hebron Research Institute, Barcelona, Spain.
  3. Unit of Synthesis and Biomedical Applications of Peptides, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Consejo Superior de Investigaciones Científicas, Barcelona, Spain.
  4. Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain.
  5. Rheumatology Research Group, Vall d’Hebron Research Institute, Barcelona, Spain
  6. Arthritis Unit, Rheumatology Department, Hospital Clinic of Barcelona, Spain. sanmarti@clinic.cat

CER14163
2021 Vol.39, N°5
PI 1142, PF 1143
Letter

Free to view
(click on article PDF icon to read the article)

PMID: 33666163 [PubMed]

Received: 28/10/2020
Accepted : 27/11/2020
In Press: 03/03/2021
Published: 31/08/2021

Rheumatology Article